Abstract
The increase in migraine frequency—with shift towards chronicity—promotes an enhancement of the central hypersensitivity which has been linked with fibromyalgia and myositis (FM). Migraine patients with FM have been known to have higher burden of headaches across studies, but this is the first population-based study to evaluate disability and morbidity in migraine patients with concurrent FM. We performed a retrospective cross-sectional analysis of migraine hospitalizations using the nationwide database to determine cost, hospital stay, disability, and discharge disposition. This analysis was performed in migraine patients with and without FM using ICD-9-CM codes. We performed weighted analyses using chi-square and t test. Among year 2014 hospitalizations, we identified FM patients and regression analysis was performed to evaluate whether migraine or other headache disorders were predictors of FM hospitalization. Between years 2003 and 2014, of the total 446,446 migraine hospitalizations, 22,735(5.09%) patients had concurrent FM. Migraine patients with FM had higher prevalence of loss of function (8.4% vs. 6.5%, p<0.0001) and transfer to rehabilitation facilities (5.5% vs. 4.5%, p<0.0001) compared to those without FM. Migraine patients with FM also had higher hospitalization stay and cost. Through regression analysis, we found that migraine (aOR, 3.03; p<0.0001), cluster headache (aOR, 1.71; p=0.0124), and tension headache (aOR, 1.87; p<0.0001) were highly associated with FM hospitalization. FM was associated with significant increase in disability, morbidity, hospitalization stay, and cost in patients admitted with migraine. On the basis of this study finding, it would be reasonable to screen migraine patients with depression, anxiety, or other psychiatric disorders for symptoms of FM to mitigate the burden.
Similar content being viewed by others
References
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.
de Tommaso M. Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches. Expert Rev Neurother. 2012;12(3):287–95; quiz 296. https://doi.org/10.1586/ern.11.190.
Centonze V, Bassi A, Cassiano MA, Munno I, Dalfino L, Causarano V. Migraine, daily chronic headache and fibromyalgia in the same patient: an evolutive "continuum" of non organic chronic pain? About 100 clinical cases. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2004;25(Suppl 3):S291–2. https://doi.org/10.1007/s10072-004-0314-4.
Whealy M, Nanda S, Vincent A, Mandrekar J, Cutrer FM. Fibromyalgia in migraine: a retrospective cohort study. J Headache Pain. 2018;19(1):61. https://doi.org/10.1186/s10194-018-0892-9.
Peres MF, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology. 2001;57(7):1326–8. https://doi.org/10.1212/wnl.57.7.1326.
Beyazal MS, Tufekci A, Kirbas S, Topaloglu MS. The impact of fibromyalgia on disability, anxiety, depression, sleep disturbance, and quality of life in patients with migraine. Noro Psikiyatri Arsivi. 2018;55(2):140–5. https://doi.org/10.5152/npa.2016.12691.
Fitzcharles MA, Yunus MB. The clinical concept of fibromyalgia as a changing paradigm in the past 20 years. Pain Res Treat. 2012;2012:184835–8. https://doi.org/10.1155/2012/184835.
Giamberardino MA, Affaitati G, Martelletti P, Tana C, Negro A, Lapenna D, et al. Impact of migraine on fibromyalgia symptoms. J Headache Pain. 2015;17:28. https://doi.org/10.1186/s10194-016-0619-8.
Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia : an international journal of headache. 2006;26(4):451–6. https://doi.org/10.1111/j.1468-2982.2005.01060.x.
Kucuksen S, Genc E, Yilmaz H, Salli A, Gezer IA, Karahan AY, et al. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol. 2013;32(7):983–90. https://doi.org/10.1007/s10067-013-2218-2.
Marcus DA, Bhowmick A. Fibromyalgia comorbidity in a community sample of adults with migraine. Clin Rheumatol. 2013;32(10):1553–6. https://doi.org/10.1007/s10067-013-2310-7.
de Tommaso M, Sardaro M, Serpino C, Costantini F, Vecchio E, Prudenzano MP, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia : an international journal of headache. 2009;29(4):453–64. https://doi.org/10.1111/j.1468-2982.2008.01754.x.
de Tommaso M, Federici A, Serpino C, Vecchio E, Franco G, Sardaro M, et al. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain. 2011;12(6):629–38. https://doi.org/10.1007/s10194-011-0377-6.
Marcus DA, Bernstein C, Rudy TE. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome. Clin Rheumatol. 2005;24(6):595–601. https://doi.org/10.1007/s10067-005-1121-x.
Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin N Am. 1989;15(1):1–18.
MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3(6):354–61. https://doi.org/10.1016/s1474-4422(04)00768-9.
Aloisi AM, Bonifazi M. Sex hormones, central nervous system and pain. Horm Behav. 2006;50(1):1–7. https://doi.org/10.1016/j.yhbeh.2005.12.002.
Mongini F, Deregibus A, Rota E. Psychiatric disorders and muscle tenderness in episodic and chronic migraine. Expert Rev Neurother. 2005;5(5):635–42. https://doi.org/10.1586/14737175.5.5.635.
Costantini R, Affaitati G, Wesselmann U, Czakanski P, Giamberardino MA. Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients. Pain. 2017;158(10):1925–37. https://doi.org/10.1097/j.pain.0000000000000992.
Yilmaz V, Aras B, Erturk FA, Cakci FA, Umay E. Migraine in patients with fibromyalgia and outcomes of greater occipital nerve blockage. Clin Neurol Neurosurg. 2019;181:54–7. https://doi.org/10.1016/j.clineuro.2019.04.004.
McCormick PJ, Lin HM, Deiner SG, Levin MA. Validation of the all patient refined diagnosis related group (APR-DRG) risk of mortality and severity of illness modifiers as a measure of perioperative risk. J Med Syst. 2018;42(5):81. https://doi.org/10.1007/s10916-018-0936-3.
Baram D, Daroowalla F, Garcia R, Zhang G, Chen JJ, Healy E, et al. Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respirat Pulm Med. 2008;2:19–25.
Author information
Authors and Affiliations
Contributions
U.P. and P.M. conceive of the idea and performed biostatistics and analysis. R.S. and P.M. wrote the manuscript with support from A.K., B.R., and S.S. who contributed to the literature review, tables, figure, and citation. A.K. and T.K. supervised the project.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that there is no conflict of interest.
Informed Consent
The data has been taken from Nationwide Inpatient Sample, which is a deidentified database from “Health Care Utilization Project (HCUP)” sponsored by the Agency for Healthcare Research and Quality, so informed consent or IRB approval was not needed for the study. The relevant ethical oversight and HCUP Data Use Agreement (HCUP-4Q28K90CU) were obtained for the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
About this article
Cite this article
Patel, U.K., Malik, P., Sheth, R. et al. Fibromyalgia and Myositis Linked to Higher Burden and Disability in Patients with Migraine. SN Compr. Clin. Med. 1, 882–890 (2019). https://doi.org/10.1007/s42399-019-00129-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42399-019-00129-7